STANDARDIZATION OF “FLUCAM” OINTMENT
Article Sidebar
Main Article Content
Abstract
In recent years, the interest of specialists in the problem of immunocorrective therapy has increased significantly, primarily due to the significant increase in immunodeficiency conditions and the understanding that the development of most pathological processes is caused by a disruption in the functions of the immune system. Immunotropic drugs of plant origin have a gentle effect on the body, restore immunity, mobilize the reserve defense mechanism, and increase the effectiveness of therapy due to the content of various biologically active substances. The inclusion of plant immunomodulators that affect both humoral and cellular immune responses, as well as factors of non-specific resistance of the body, in the treatment of various immunodeficiency conditions makes it possible to increase the effectiveness of the therapy. Taking into account the above circumstances, the authors obtained a dry extract from a multi-component plant composition, which served as the basis for creating an ointment with immunomodulatory action “Flucam”. The latter, being practically non-toxic and having no side effects on the body, exhibits a pronounced immunomodulatory effect, surpassing in its activity known foreign analogues. In order to promote the said ointment in medical practice, studies have been conducted on its standardization. The characteristics of authenticity and quality indicators of the ointment have been determined, and methodological techniques for the qualitative and quantitative determination of the main active substances - glycyrrhizic acid and tannins - have been developed. At the same time, an important place is given to the so-called "end-to-end standardization", which is based on the assessment of the quality of the original plant composition, dry extract and the ointment obtained from it by the content of the same biologically active compounds. This, to a certain extent, allows for a sufficient guarantee of the quality and constant composition of the finished product.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
L.V.Luss, N.I.Ilyina, A.E.Shulzhenko, E.V.Nazarova, N.V.Shartanova and O.I.Sidorovich, The main causes and factors of the formation of immune dysfunctions in humans and modern approaches to their correction. Russian Allergological Journal. 16 (2019) 11.
R.M.Khaitova and R.I.Ataullakhanova Immunotherapy. - Moscow: GEOTAR-Media, (2011) 672.
Yu.N.Fedorov, Immunocorrection: application and mechanism of action of immunomodulatory drugs // Veterinary medicine. 2 (2005) 3-6.
Topuria L.Yu., Stadnikov A.A., Topuria G.M. Pharmacocorrection of immunodeficiency states in animals. - Orenburg, 2008. -176 p.
P.A.Krasochko, Immunocorrection in clinical veterinary medicine: Monograph. - Minsk: Tekhnoperspektiva. (2008) 507.
V.M.Manko, R.V.Petrov and R.M.Khaitov, Immunomodulation: history, development trends, current state and prospects. Immunology. 23 (2002) 132-139.
A.D.Bakuridze, M.Sh.Kurtsikidze, V.M.Pisarev, R.V.Makharadze and D.T.Berashvili, Immunomodulators of plant origin // Chemical and pharmaceutical journal. 8 (1993) 43-47.
V.V.Lazareva, T.V.Plechev, L.I. Morugova and Samigullina D.N. Plants that stimulate immunity. – Ufa. (2005) 96.
T.Fukai, H.Sakagami, M.Toguchi et. al., Cytotoxic activity of low molecular weight polyphenols against human oral tumor cell lines. Anticancer Res. 20 (2000) 2525-2536.
J.B.Hudson, Applications of the Phytomedicine Echinacea purpurea (Purple Coneflower) in Infectious Diseases //Journal of Biomedicine and Biotechnology. (2012) 16.
V.I.Korzhov, M.M.Negmatov, T.A.Sokirko and N.V. Rudnaya, Use of multicomponent collection in complex therapy of patients with tuberculosis Third Ukrainian Conf. on Medical Botany. (1992) 17-18.
V.P. Osetrov, Alternative phytotherapy. (1993) 271 p.
K.Z.Alimkulova, F.F.Urmanova, B.A.Imamaliev, T.R.Eryigitov and M.S. Isadjanov, Study Of Substitute Toxicity And General Pharmacological Activity Of The “Flucam” // International Journal of Advanced Science and Technology. 29 (2020) 3115-3127.
K.Z.Alimkulova, F.F.Urmanova, B.A.Imamaliev, L.K. Elmurodov Study of the immunomodulatory activity of the drug “Flucam”. Pharmaceutical journal. 2 (2020) 88-92.
K.Z.Alimkulova, F.F.Urmanova, B.A.Imamaliev, L.K.Elmurodov and M.S. Isadzhanov, Study of the effect of the drug “Flucam” on blood count parameters in the immunosuppression model. Pharmaceutical journal. 3 (2020) 97-106.
K.Z.Alimkulova, F.F.Urmanova, Sh.Sh.Gulyamov and B.A.Imamaliev, Study of acute toxicity, local irritant and allergenic effects of dry extract “Flucam” Pharmaceutical Bulletin of Uzbekistan. 1 (2019) 60-65.
K.Z.Alimkulova, F.F.Urmanova, B.A.Imamaliev Screening study of the immunomodulatory activity of herbal compositions based on naked licorice. Proceedings of the Republican scientific and practical conference “Current state of the pharmaceutical industry: problems and prospects”. – (2019) 466-468.
I.A.Samylina and I.A. Balandina, Ways of using medicinal plant materials and their standardization. http: / www.rusvrach.ru/articles/ farm-02-2004, pp. 39-41.
V.A.Ermakova, Pharmacognostic study and standardization of fees, briquettes, herbal powders. - Abstract of Doctor of Pharmaceutical Sciences. – (1999) 42.
V.B.Khobrakova, A.B.Shobolova and S.M. Nikolaev, Effect of dry extract of Sophora flavescens on humoral immune response indices. Bulletin of the SB RAMS. 67 (2009). 228-229.
A.A.Markaryan. Current state of standardization of medicinal plant materials and phytopreparations obtained from them. (2004) 13-14.
N.A.Kolomiets, T.V.Kamenkina, EA Luksha et al., Problems of quality of medicinal plant materials sold on the pharmaceutical market of Russia. Pharmacy. (8) 2008 47-52.
O.G.Potanina Improvement of standardization and quality control of medicinal plant raw materials and medicinal forms from them based on the microscopic method of examination. - Diss. doc. pharm. sciences. - Moscow, (2004) 424.
European Pharmacopoeia. 1 (2019) 22-24.
State Pharmacopoeia of the Republic of Uzbekistan. First edition, 1. (2021) 380.
T.V.Kamenkina, N.A.Kolomiets and EA Luksha, International Conference on Harmonisation of Technical requirements for registration of Pharmaceuticals for Human USE. ICH. Proceedings of the Second International Conference on Harmonization. - Brussels, (2008) 2.
A.A. Markaryan, Current state of standardization of medicinal plant raw materials and phytopreparations obtained from them. (2004) 13-14.
S.Takeda, T.Shigudzumi and J.Ohta, Japan Pharm. Soc. 60 (2002) 887-889.
K.Z.Alimkulova and F.F.Urmanova Standardization of new herbal composition “Flucam”. (2020) 10784-10792.
The Japanese Pharmacopoeia seventeenth edition, Official from April. 1 (2016) 1295.
A.Ivanov, and B.Petrov, “Stability studies of herbal extracts: a review” Pharmaceutical Science, 12(3) (2018) 123-132.
Smith J.D. Factors affecting the stability of herbal preparations. Journal of Natural Products. 82 (2019) 957-965.